These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20405739)

  • 1. [Comparative characteristics of haemostasis in elderly patients with diabetes mellitus type I and II].
    Zakharova MIu; Kliuchereva NN; Kuznik BI; Nomokonova IN
    Adv Gerontol; 2009; 22(4):676-9. PubMed ID: 20405739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Status of the system of hemostasis in patients with non-insulin-dependent and insulin-dependent diabetes mellitus without clinical manifestation of vessel pathology].
    Harbarchuk OI
    Ukr Biokhim Zh (1978); 1998; 70(4):134-9. PubMed ID: 9848216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Method of treatment and platelet aggregation in patients with diabetes mellitus type II].
    Bresler M; Gumprecht J; Strojek K; Grzeszczak W; Trautsolt W
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():35-7. PubMed ID: 8516205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ADP-induced aggregation of human platelets in diabetes mellitus].
    Chirkov IuIu; Tyshchiuk IA; Severina IS; Starosel'tseva LK
    Vopr Med Khim; 1990; 36(4):20-2. PubMed ID: 2238525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus].
    Lapotnikov VA; Moiseev SI
    Ter Arkh; 1988; 60(9):31-5. PubMed ID: 3217876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus.
    Antonopoulou S; Fragopoulou E; Karantonis HC; Mitsou E; Sitara M; Rementzis J; Mourelatos A; Ginis A; Phenekos C
    J Med Food; 2006; 9(3):356-62. PubMed ID: 17004898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microcirculatory hemostasis in children with insulin-dependent diabetes mellitus].
    Turkina TI; Marchenko LF; Savenkova MS; Sapelkina LV
    Probl Endokrinol (Mosk); 1993; 39(4):7-10. PubMed ID: 8415537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of the antiaggregants ticlid and diabeton in correcting chronic intravascular microcoagulation of the blood in diabetic patients].
    Velikov VK; Saltykov BB; Galkina AK; Kabaeva EV; Frolova AI; Privalova EV; Savina TS; Zelenchuk NM; Shubina OI; Iarovaia LD
    Ter Arkh; 1991; 63(10):44-9. PubMed ID: 1805420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect evidence of impairment of platelet desaturase enzymes in diabetes mellitus.
    Jones DB; Carter RD; Mann JI
    Horm Metab Res; 1986 May; 18(5):341-4. PubMed ID: 3013745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombin III and alpha-2-antiplasmin activities compared with other hemostasis parameters in uncomplicated diabetes mellitus, type 2].
    Kotschy M; Drewniak W; Graczykowska-Koczorowska A; Listopadzki D
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):17-8. PubMed ID: 1409034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes mellitus and platelet half-life].
    Banfi L; Vecchi C; Galetti A; Giussani R; Guzzini F
    Clin Ter; 1987 May; 121(4):305-10. PubMed ID: 2973867
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin management of type I and type II diabetes in pregnancy.
    Hare JW
    Clin Obstet Gynecol; 1991 Sep; 34(3):494-504. PubMed ID: 1934701
    [No Abstract]   [Full Text] [Related]  

  • 13. Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects.
    Mutus B; Rabini RA; Staffolani R; Ricciotti R; Fumelli P; Moretti N; Martarelli D; Mazzanti L
    Diabetologia; 2001 Aug; 44(8):979-82. PubMed ID: 11484074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of thymomimetic vilon on blood coagulation system and fibrinolisis in diabetes mellitus type 1 patients of different age].
    Kuznik BI; Kolesnichenko LR; Kliuchereva NN; Pinelis IuI; Ryzhak GA; Khamaeva TsB
    Adv Gerontol; 2006; 19():107-15. PubMed ID: 17152731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet adhesiveness in diabetes mellitus with relation to treatment.
    Samal KK; Sahu CS; Nanda RC
    J Indian Med Assoc; 1991 Jun; 89(6):155-7. PubMed ID: 1748786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of subcutaneous insulin management protocols and order sets in inpatient diabetes management.
    Houlden RL; Moore S; Cornish W; Tiwana K
    Can J Diabetes; 2014 Apr; 38(2):101-17. PubMed ID: 24690505
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin-treated diabetes in Tasmania: population-based clinical characteristics and their possible implications for diabetic health care in Australia.
    King H; Dixon J; Senator G; Zimmet P
    Med J Aust; 1989 Oct; 151(8):444, 446, 448, 450. PubMed ID: 2687669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multivariate analysis for the understanding of typical diabetic hemostasis criteria. 1: Plasma markers].
    Syrbe G; Schröder H; Keil E; Jütte A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):717-23. PubMed ID: 1709905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of vilon on the immunity status and coagulation hemostasis in patients of different age with diabetes mellitus].
    Kuznik BI; Isakova NV; Kliuchereva NN; Maleeva NV; Pinelis IS
    Adv Gerontol; 2007; 20(2):106-15. PubMed ID: 18306698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypoglycemia in diabetes mellitus. Symptoms, epidemiology, physiopathology, causes and treatment].
    Madsbad S
    Ugeskr Laeger; 1992 Jan; 154(5):246-50. PubMed ID: 1736455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.